Every October, Breast Cancer Awareness Month points us toward the front end of the story: get screened, know your risk, catch it early. That message saves lives and deserves repeating. But what happens when someone hears the words that awareness campaigns prepare us to act on?

“You have cancer.”

Suddenly, knowing that early detection matters is not enough. The questions become immediate and personal. Who do I see first? Why am I waiting for another result? How will treatment affect my life?

Two recent episodes of STO’s Voices in Oncology podcast explore that unfolding experience. In “The First 30 Days After Diagnosis” and “Breast Cancer Treatment: 3 Questions Patients Are Afraid to Ask”, oncology nurse navigator Amy DePue and oncology pharmacist Aimee Faiso cover both the first month and the long road of treatment.

Together, these conversations reveal something important. Patients need help not only finding answers but also recognizing which questions to ask and feeling comfortable enough to ask them.

After a diagnosis, patients may feel that everything needs to happen immediately. Every unanswered call or unscheduled appointment can raise the same worry: Are we losing time?

Meanwhile, the care team is requesting records, reviewing pathology, awaiting biomarker results, arranging imaging, and coordinating specialist visits. That work helps determine the treatment recommendation, but much of it is invisible to the person waiting at home.

An early conversation can make that interval more understandable. A navigator can explain what information is still needed, what happens next, and whom to contact with questions. The aim is not to dismiss the urgency patients feel or suggest that all delays are harmless. It is to explain which steps are necessary, how the team is assessing urgency, and when the patient should expect an update.

Later, a different uncertainty can emerge. A patient who has completed surgery and other initial treatments may wonder why medication will continue for years. Does that mean treatment did not work?

Here, too, explaining the purpose matters. For some people with breast cancer, long-term endocrine therapy is intended to lower recurrence risk. Understanding that role can help patients distinguish an ongoing prevention strategy from the fear that something has gone wrong.

Patients deserve both a plan and an explanation of why it looks the way it does.

Early after diagnosis, people often do not know what they do not know. They may not understand why several specialists are involved, what a biomarker result means, or when fertility, work leave, and treatment education should enter the conversation.

Care teams can help by introducing these topics before patients realize they need to ask.

As treatment continues, the gap may change. Patients know exactly what is bothering them but hesitate to say it out loud.

Hot flashes are interrupting sleep. Desire has changed. Intimacy feels uncomfortable. Their body feels unfamiliar. Yet the appointment focuses on test results and treatment response, and they leave without mentioning any of it.

These concerns are not distractions from cancer care. They are part of the experience of receiving it. Clinicians can make that clear by asking directly about side effects, sexual health, and emotional well-being rather than waiting for patients to introduce a sensitive subject.

Patients can also begin simply: “There’s something I’m embarrassed to ask,” or “This side effect is affecting my daily life.”

The hosts’ message is to talk with the care team before changing or stopping treatment. A problem the team does not know about is a problem it cannot help address.

Two STO handouts turn these ideas into something you can use at your next appointment:

Bring a notebook and, if you can, a second set of ears. The handouts are starting points, not a script, and your own care team can answer what is specific to you.

This October, let’s add another message to “get screened”: if you are in treatment, you don’t have to figure it out alone or stay silent about what is hard.

To hear the conversations behind this blog:

Additional episodes and resources are available at https://sto-online.org/voices-in-oncology-podcast/.